000 04332nam a22004455i 4500
999 _c362599
_d362599
_x1
001 362599
003 ES-MaUEC
005 20230102121557.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 210823s2021 si | s |||| 0|eng d
020 _a9789811636158
024 7 _a10.1007/978-981-16-3615-8
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRC848.H44
_b2021 EB
245 0 0 _aHepatitis B Virus and Liver Disease
_cedited by Jia-Horng Kao
250 _aSecond edition 2021
264 1 _aSingapore
_bSpringer International Publishing
_c2021
300 _a1 recurso en línea (XII, 508 páginas)
_b42 ilustraciones, 39 ilustraciones a color
336 _2rdacontent
_aTexto
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _aArchivo de texto
_bPDF
505 0 _a1. Molecular Virology and Life Cycle of Hepatitis B Virus -- 2. Unmet Needs in Basic Research of Hepatitis B Virus Infection: In Vitro and In Vivo Models -- 3. Unmet Needs Clinical Research Hepatitis B -- 4. Immunopathogenesis of Hepatitis B Virus Infection -- 5. Pathology of Hepatitis B Virus (HBV) Infection and HBV-related Hepatocellular Carcinoma -- 6. Molecular Carcinogenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma -- 7. Epidemiology and Natural History of Hepatitis B Virus Infection -- 8. Hepatitis B Vaccines -- 9. Viral and Host Factors Affecting Disease Progression of Hepatitis B Virus Infection -- 10. Novel Biomarkers for the Management of Chronic Hepatitis B Virus Infection -- 11. Chronic hepatitis B virus infection: Non-invasive assessment of liver disease -- 12. Chronic Hepatitis B Virus Infection: Interferon Therapy and Long-Term Outcomes -- 13. Nucleos(t)ide therapy and long-term outcomes -- 14. Combination therapy -- 15. Treatment of HCV, HDV or HIV Coinfections -- 16. Management of Chronic Hepatitis B Virus Infection in Children and Pregnant Women -- 17. Occult Hepatitis B Infection -- 18. Hepatitis B Virus Reactivation and Management of Patients undergoing Immunosuppression -- 19. Novel Therapy for Functional Cure of Chronic Hepatitis B Virus Infection -- 20. Is Cure of Hepatitis B infection a mission possible?
520 _aThis book provides a comprehensive, state-of-the art review of HBV infection and liver disease. It discusses new data on basic and translational medicine, including the viral life cycle, the immunopathogenesis of virus-induced chronic hepatitis, viral and host genetic factors affecting disease progression, and the mechanism of virus-induced hepatocarcinogenesis, as well as their potential applications in daily clinical practice. The clinical aspects of chronic HBV infection are examined in chapters on the global epidemiology, efficacy of HBV vaccination, natural history, novel biomarkers, co-infections with HCV, HDV or HIV, and management of special populations including children, pregnant women and patients undergoing immunosuppressive therapy. Further, it describes the advances and perspectives in the development of novel antiviral treatments for possible functional cure of HBV infection. In this second edition, authors provides recent updates in epidemiology, biomarkers, antivirus therapy, and novel therapy for functional cure of chronic hepatitis B virus infection. The book is a valuable resource for medical students, physicians, and researchers who are interested in management of patients with chronic HBV infection and investigation HBV infection.
988 _aSpringer_Medicine_2021
650 7 _2embne
_9158777
_aHepatitis B
650 7 _2embne
_9169917
_aHígado
_xEnfermedades
650 7 _2embne
_aHepatitis víricas
_9145703
700 1 _aKao, Jia-Horng
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_9682926
776 0 8 _iPrinted edition:
_z9789811636141
776 0 8 _iPrinted edition:
_z9789811636165
776 0 8 _iPrinted edition:
_z9789811636172
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-16-3615-8
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
998 _b03/2022
_dz
_esc
_zSI